Vinge has advised AMF and Folksam in connection with their SEK 5 bn reinvestment in Volvo Cars in connection with the redemption of existing preference shares.
Vinge has advised the risk and compliance software company NAVEX Global in connection with its acquisition of WhistleB Whistleblowing Centre AB, a company which offers an integrated whistleblowing case management system with reporting options in over 60 languages used by customers in more than 150 countries.
Vinge has advised the pharmaceutical development company Xspray Pharma in connection with a directed share issue, whereby Xspray receives proceeds of approximately SEK 122 million.
Vinge advised Nordea Bank Abp and Citigroup Global Markets Limited which are acting as Global Coordinators and Bookrunners in connection with a directed share issue of SEK 312 million in Better Collective A/S through an accelerated book building procedure.
Vinge has assisted Vostok New Ventures Ltd (“Vostok”) in connection with an investment by a number of investors of in total USD 85 million in Voi Technology AB, a company that provides an electric scooter sharing service.
On 7 November 2019, Vonovia SE announced, through its indirectly wholly-owned subsidiary HomeStar InvestCo AB, a mandatory cash offer to the shareholders of Hembla AB (publ) to acquire all shares in Hembla.
Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) has announced a recommended public offer to the shareholders of Hemfosa Fastigheter AB (publ) (“Hemfosa”) to tender all their shares in Hemfosa to SBB.
Vinge has advised Skandinaviska Enskilda Banken AB (publ) as to Swedish law in connection with the issuance of Additional Tier 1 Capital (AT1) of USD 900 million to optimise its capital structure.
Vinge has advised Vicore Pharma, a Swedish rare disease company focused on interstitial lung diseases and related indications, in connection with a directed share issue whereby Vicore Pharma will receive approximately SEK 125 million in issue proceeds.
